Remedy Plan Remedy Plan Therapeutics is a biotechnology company developing drugs that halt tumor growth and disrupt the cancer stem cells that cause metastasis. | ![]() Rise Therapeutics Rise Therapeutics is a biotech company that develops immunological-based biologics using an oral delivery platform. | ![]() Alchemab Therapeutics Alchemab Therapeutics is a biotech company developing novel products for patients with diseases by harnessing naturally protective antibodies. | ![]() Rgenta Rgenta Therapeutics is a company developing RNA-targeting medicines focused on oncology and neurological disorders. | ![]() Amunix Pharmaceuticals Amunix Pharmaceuticals is a biopharmaceutical company focused on immuno-oncology. | |
Founding Date | Founding Date 2011 | Founding Date 2014 | Founding Date 2019 | Founding Date 2020 | Founding Date 2006 |
Type | Type Private | Type Private | Type Private | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations HQ | Locations Rockville, US HQ | Locations London, GB HQ Babraham, GB | Locations Woburn, US HQ | Locations South San Francisco, US HQ |
Employees | Employees 15 | Employees 196% increase | Employees 512% decrease | Employees 299% decrease | Employees 42 |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 200k (over 8 years ago) | Latest funding round $ 71.8m (about 5 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 10.1m | Total funding raised $ 200k | Total funding raised $ 71.8m | Total funding raised N/A | Total funding raised $ 190m |

Rise Therapeutics is a biotech company that develops immunological-based biologics using an oral delivery platform.
View company
Alchemab Therapeutics is a biotech company developing novel products for patients with diseases by harnessing naturally protective antibodies.
View company
Rgenta Therapeutics is a company developing RNA-targeting medicines focused on oncology and neurological disorders.
View company
Amunix Pharmaceuticals is a biopharmaceutical company focused on immuno-oncology.
View company